Study of norethindrone in contraception.
Goldzieher
J W
JW
Moses
L E
LE
Ellis
L T
LT
D001519:Behavior; D002490:Central Nervous System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007989:Libido; D008656:Mestranol; D009640:Norethindrone; D010060:Ovulation; D012106:Research; D012725:Sexual Behavior
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D009640:Norethindrone
Behavior; Central Nervous System Effects; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Mode Of Action; Evaluation; Family Planning; Increased Libido; Mestranol; Norethindrone; Oral Contraceptives; Oral Contraceptives, Combined; Ovulation Suppression; Research Methodology; Reversibility; Sex Behavior